Mid-Market: S&P/ASX 200 Trading Higher By 0.41%; All 11 Sectors Are Trading In Green Zone

On 19 December 2023, at AEDT 11:30 AM, the benchmark index S&P/ASX 200 is trading higher today, gaining 30.60 points or 0.41%, and is currently trading at 7,457.50 levels. All 11 sectors are trading higher along with the S&P/ASX 200. The Energy and A-REIT sectors are the top 2 gaining sectors, gaining 0.82% and 0.48% in their index values.

Liontown Resources Limited (ASX: LTR) and Neuren Pharmaceuticals Limited (ASX: NEU) are the top-gaining stocks, gaining 9.044% and 8.964% in their stock prices. On the other hand, Weebit Nano Ltd (ASX: WBT) and Tabcorp Holdings Limited (ASX: TAH) are the top-losing stocks and are declining by 4.055% and 2.763% in their stock prices.

Factors influencing the market-

• The S&P/ASX 200 is gaining today, tracking a Wall Street rally, with energy leading gains after oil prices jumped on fears of supply disruptions.
• Telix Pharmaceuticals Limited’s shares are declining despite it submitted a license application to the US Food and Drug Administration (FDA) for a radiopharmaceutical imaging agent for kidney cancer.
• Origin Energy rallied today after announcing another £280 million ($530 million) into British energy retailer and tech platform Octopus Energy.
• Oil rose nearly 2% as investors worried about disruptions to maritime trade and supply costs after the Iran-aligned Yemeni Houthi militant group attacked ships in the Red Sea.
• The Dow has closed flat, the S&P 500 up by 0.45%, and the NASDAQ ended higher by 0.65%.
• Hang Seng is down by 0.97%, and FTSE 100 is up by 0.50%

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com